Your browser doesn't support javascript.
loading
GSK-3 Inhibitors: A Double-Edged Sword? - An Update on Tideglusib.
Mathuram, Theodore Lemuel; Reece, Lisa M; Cherian, Kotturathu Mammen.
Afiliação
  • Mathuram TL; Department of Stem Cell and Tissue Engineering, Frontier Mediville (A Unit of Frontier Lifeline and Dr. K. M. Cherian Heart Foundation), Affiliated to University of Madras, Chennai, Tamil Nadu, India.
  • Reece LM; Sealy Center for Vaccine Development, World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.
  • Cherian KM; Department of Cardiothoracic Surgery, Frontier Lifeline Hospital, Chennai, Tamil Nadu, India.
Drug Res (Stuttg) ; 68(8): 436-443, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29388174
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiadiazóis / Quinase 3 da Glicogênio Sintase / Inibidores Enzimáticos / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiadiazóis / Quinase 3 da Glicogênio Sintase / Inibidores Enzimáticos / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article